InspireMD Inc. (NSPR) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning and welcome to InspireMD's fourth quarter and full year 2025 earnings conference call. Currently, all participants are in listen-only mode. We will facilitate a question-and-answer session towards the end of today's call. This call is being recorded for replay purposes. I would now like to turn the call over to Webb Campbell from Gilmour & Group for introductory disclosures. Thank you for joining us for the InspireMD fourth quarter and full year 2025 conference call. Joining us today from InspireMD are Marvin Flawson, Chief Executive Officer, and Mike Lawless, Chief Financial Officer, and Shane Gleason, Chief Commercial Officer. During this call, management will make forward-looking statements, which are based upon management's current expectations, beliefs, and projections, many of which, by their nature, are inherently uncertain. These forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those expressed in such forward-looking statements. For more information about these risks, please refer to the risk factors described in InspireMD's most recently filed periodic report on Form 10-K and Form 10-Q, or any updates in its current report on Form 8-K filed with the U.S. Securities and Exchange Commission and InspireMD's press release that accompanies this call. particularly the cautionary statements made in it. This call contains time-sensitive information that is accurate only as of today, March 18, 2026. Except as required by law, InspireMD disclaims any obligation to publicly update or revise any information to reflect events or circumstances that occur after this call. It is now my pleasure to turn the call over to Marvin Flossman, Chief Executive Officer. Marvin, please go ahead. Thank you a...